Infection and Malignancy in Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America, E-Book


Book Description

This issue of Rheumatic Disease Clinics will include articles such as: Vaccines and Biologics- efficacy and toxicity; Improving Vaccine administration in Practice; HCV and rheumatology; HBV reactivation and rheumatic disease; Herpes zoster in rheumatic diseases; Opportunistic infections in biologic therapy, risk and prevention; and many more!




Cancer and Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America, E-Book


Book Description

This issue of Rheumatic Disease Clinics, guest edited by Dr. John Davis, will discuss Cancer and Rheumatic Diseases. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: rheumatic drugs and malignancy potential, biologic drugs and cancer, methotrexate and cancer, managing rheumatoid arthritis with cancer, Sjogren’s Syndrome and cancer, lupus and cancer, scleroderma and cancer, cancer and spondylarthritis, and cancer immunotherapy.




Cancer and Rheumatic Diseases, an Issue of Rheumatic Disease Clinics of North America


Book Description

This issue of Rheumatic Disease Clinics, guest edited by Dr. John Davis, will discuss Cancer and Rheumatic Diseases. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: rheumatic drugs and malignancy potential, biologic drugs and cancer, methotrexate and cancer, managing rheumatoid arthritis with cancer, Sjogren's Syndrome and cancer, lupus and cancer, scleroderma and cancer, cancer and spondylarthritis, and cancer immunotherapy.




Rheumatology, An Issue of Medical Clinics of North America


Book Description

Guest edited by Dr. Brian Mandell, this issue of Medical Clinics of North America will cover several key areas of interest related to Rheumatology. This issue is one of six selected each year by our series Consulting Editor, Dr. Jack Ende. Articles in this issue include but are not limited to: Vaccinations in Patients with Rheumatic Disease: Consider Disease and Therapy, Rheumatic Complications of Immune Checkpoint Inhibitors, Managing the Cardiovascular Risk in Patients with Rheumatic Disease, Statin associated myalgias and muscle injury – recognizing and managing both while still lowering the low-density lipoprotein, Perioperative Management of Rheumatic Disease and Therapies, Fibromyalgia: Recognition and Management in the Primary Care Office, Management and Cure of Gouty Arthritis, Update on the Treatment of Giant Cell Arteritis and Polymyalgia Rheumatica, Suspecting and Diagnosing the Patient with Spondyloarthritis and What to Expect from Therapy, Pregnancy and Management in Women with Rheumatoid Arthritis, Systemic Lupus Erythematosus and Obstetrical Antiphospholipid Syndrome, Rheumatoid Arthritis: Early Diagnosis and Treatment, Management of Knee Osteoarthritis: What Internists Need to Know, Antinuclear antibody (ANA) testing for the diagnosis of Systemic Lupus Erythematosus (SLE), and more.




Health disparities in rheumatic diseases: Part II, An Issue of Rheumatic Disease Clinics of North America, E-Book


Book Description

This issue of Rheumatic Disease Clinics, guest edited by Dr. Candace Feldman, is Part II of a two-part issue covering Health Disparities in Rheumatic Diseases. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: Disparities in Lupus Care and Outcomes among U.S. Medicaid Beneficiaries, Understanding Risk Factors for Poor Outcomes in a Multiethnic Longitudinal Cohort, Impact of Psychosocial Factors on RA and Lupus Health Disparities, Racial/ethnic and geographic disparities in knee and hip osteoarthritis, Racial/ethnic Disparities in Osteoarthritis Management, Challenges and Strategies to Achieve Equitable Rheumatologic Care Across the World, Strategies to Reduce Disparities, Understanding and Addressing the Provider Biases and the Lack of Diversity in Lupus Clinical Trials, Community-engaged Research: Lupus Conversations, Leveraging Telemedicine as an Approach to Address Rheumatic Disease Health Disparities, and Understanding the Role and Challenges of Patient Preferences in Disparities in Rheumatic Disease Care.




Controversies in Rheumatology,An Issue of Rheumatic Disease Clinics of North America


Book Description

Guest edited by Drs. Jonathan Kay and Sergio Schwartzman, this issue of Rheumatic Disease Clinics will cover Controversies in Rheumatology. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman of Cedars-Sinai. Articles explore several questions, including, but not limited to: Is triple therapy or methotrexate plus a biologic the initial treatment of choice for RA patients; Is hypo or hyper-uricemia a risk requiring treatment for cardiac morbidity and mortality; Are there benefits and risks to biosimilars from a patient perspective; Should platelet-rich plasma be used to treat osteoarthritis; Is there a role for stem cell therapy to treat cartilage defects in osteoarthritis; Should any rheumatology patient, today, be treated with bone marrow ablation and stem cell transplantation; Is there effective prevention, prophylaxis, or treatment for CPPD arthritis; Is fibromyalgia a psychiatric disease or a pain syndrome; Should cyclophosphamide still be used to treat ANCA-associated vasculitis; Does methotrexate have a place in the treatment of psoriatic arthritis; Should hydroxychloroquine dosing be limited because of potential ocular toxicity; and Should generalized immunosuppression or targeted organ treatment be the best principle for overall management of SLE.




Drug Safety: Managing Innovation in Rheumatology, An Issue of Rheumatic Disease Clinics


Book Description

Edited by Drs. Jack Cush and Kathryn Dao, this issue of Rheumatic Disease Clinics of North America addresses one of the most significant issues facing the rheumatologist today––drug safety in a changing world where rheumatoid arthritis (RA) severity is less, patients are being identified and treated at a very early stage, and prevention is on the horizon. Topics covered include: communicating the risk of side effects, urate-lowering therapies, biphosphonates, biologics, malignancy risks, and administering therapies to patients with co-morbidities.




Health disparities in rheumatic diseases: Part I, An Issue of Rheumatic Disease Clinics of North America, E-Book


Book Description

This issue of Rheumatic Disease Clinics, guest edited by Dr. Candace Feldman, will Health Disparities in Rheumatic Diseases. This issue is one of four selected each year by series Consulting Editor, Dr. Michael Weisman. Topics discussed in this issue include, but are not limited to: Disparities in Rheumatology Through the Lens of Critical Race Theory; Use of Quality Metrics to Identify Disparities in Lupus Care; The Role of Individual and Area-level Poverty on Lupus Disparities; Disparities in Lupus Care and Outcomes among U.S. Medicaid Beneficiaries; Disparities in Rheumatoid Arthritis Care; Disparities in Childhood-onset Lupus and Mental Health Care for Pediatric Lupus Patients; Disparities in Rheumatic Disease Care, Access and Outcomes in the First Nations Population; Impact of Psychosocial Factors on RA and Lupus Health Disparities; Racial and gender disparities among patients with Gout; Racial/ethnic and geographic disparities in knee and hip osteoarthritis; Racial/ethnic Disparities in Osteoarthritis Management; Racial disparities in systemic sclerosis; Community-engaged Research: Lupus Conversations; Leveraging Telemedicine as an Approach to Address Rheumatic Disease Health Disparities; Understanding the Role and Challenges of Patient Preferences in Disparities in Rheumatic Disease Care; Designing an Intervention to Improve Management and Care Coordination for High Risk Lupus Patients; Greatest Challenges and Strategies to Achieve Equitable Rheumatologic Care Across the World, among others.




Best Practices and Challenges to the Practice of Rheumatology, An Issue of Rheumatic Disease Clinics of North America


Book Description

Guest edited by Drs. Daniel J. Wallace and R. Swamy Venuturupalli, this issue of Rheumatic Disease Clinics will cover several key areas of interest related to Best Practices and Challenges to the Practice of Rheumatology. This issue is one of four selected each year by our series Consulting Editor, Dr. Michael Weisman of Cedars-Sinai. Articles in this issue include, but are not limited to: The Economics of Rheumatology Practice in the United States, Manpower trends in rheumatology, Challenges to practicing rheumatology in an academic center, Challenges in practicing rheumatology in a government setting, Challenges to practicing rheumatology in a small private practice setting, Challenges to working in a large multispecialty organization, Challenges to practicing pediatric rheumatology, Clinical trials in rheumatology, Challenges in having an infusion center, Implementing treatment to target in the clinic, Future directions: implementing new technologies in clinical practice, Possible Challenges in Optimizing Medical Education for Rheumatologists, and the challenges of approaching and managing gout.




Digestive and Hepatic Aspects of the Rheumatic Diseases, An Issue of Rheumatic Disease Clinics of North America, E-Book


Book Description

This issue of Rheumatic Disease Clinics, guest edited by Dr. Liron Caplan, will cover a number of key topics related to the digestive and hepatic aspects of rheumatic disease. The articles in this issue will include: Gastrointestinal and Hepatic Disease in Systemic sclerosis, Gastrointestinal and Hepatic Disease in Spondyloarthritis, Gastrointestinal and Hepatic Disease in Systemic Lupus erythematosus, Gastrointestinal and Hepatic Disease in Rheumatoid Arthritis, Gastrointestinal and Hepatic Disease in Behcets, Gastrointestinal and Hepatic Disease in Fibromyalgia, Gastrointestinal and Hepatic Disease in Sjogren's, among others.